Palvella Therapeutics, Inc. Share Price
NASDAQ: PVLA | Small CapPalvella Therapeutics, Inc. Stock Performance
Open $149.78 | Prev. Close $150.31 | Circuit Range N/A |
Day Range $148.35 - $151.74 | Year Range $50.40 - $160.05 | Volume 5,995 |
Average Traded $149.90 |
Palvella Therapeutics, Inc. Share Price Today
As of 30 August 2026, Palvella Therapeutics, Inc.'s share price is $149.78. The stock opened at $149.78, compared to its previous close of $150.31. During today's trading session, Palvella Therapeutics, Inc.'s share price traded between $148.35 and $151.74, with an average price of $150.04. Over the past 52 weeks, the stock has recorded a high of $160.05 and a low of $50.40. In terms of performance, Palvella Therapeutics, Inc.'s share price has risen by 10.43% over the last six months and is up 179.49% on a year-on-year basis.
Palvella Therapeutics, Inc. Share Price Chart
Palvella Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.69B | PE Ratio (TTM) -40.37 | Dividend Yield N/A |
EPS (TTM) $-3.71 | Revenue (TTM) $25.90M | Return On Equity (TTM) -149.07% |
Profit Margin -161.05% | Debt to Equity 0.41 | Quarterly Earnings Growth YoY -67.31% |
Palvella Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Palvella Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania
Palvella Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $137.99 | $150.14 | +7.82% |
Jul 2026 | $149.11 | $139.25 | -9.06% |
Jun 2026 | $115.47 | $153.13 | +29.64% |
May 2026 | $129.47 | $118.12 | -7.93% |
Apr 2026 | $129.50 | $128.30 | +2.64% |
Mar 2026 | $139.98 | $125.00 | -7.84% |
Feb 2026 | $78.81 | $135.63 | +76.90% |
Jan 2026 | $100.00 | $76.67 | -26.39% |
Dec 2025 | $96.25 | $104.16 | +0.84% |
Nov 2025 | $80.00 | $103.29 | +29.12% |
Oct 2025 | $62.41 | $80.00 | +27.72% |
Sep 2025 | $53.71 | $62.63 | +16.88% |
PVLA Share Price FAQs
What is Palvella Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Palvella Therapeutics, Inc. stock?
What is PVLA's market capitalisation today?
What is PVLA's net income for the last quarter?
What is the 5 year returns of PVLA?
What is the high & low stock price of PVLA today?
Can I buy PVLA shares in India?